Empowering access through strategic partnerships
For Payers
 

Empowering access through strategic partnerships

Collaborating with payers to deliver life-changing therapies

At Biologics, we believe
 

That exceptional patient care is a team effort.

By building strong partnerships with biopharmaceutical and life sciences companies, we ensure industry-leading access to vital therapies. Our dedication is evident: we offer over 200 medications for cancer, cell and gene, and rare diseases, participate in limited distribution networks for over 115 of these therapies, and serve as the exclusive pharmacy for over 25.

Our most important bonds are with the patients we support daily. We go above and beyond to deliver superior clinical care while ensuring our patients feel genuinely valued. An overwhelming 95% of our patients rate our service as exceptional—but don’t just take our word for it. We invite you to hear directly from them.

Julie M., caregiver
Every single person that I have dealt with at Biologics has been so wonderful and kind, and I am truly grateful for you all! Thank you!

With over 500 unique contracts, our specialty pharmacy is committed to ensuring patients receive the therapies and care they deserve. Streamlined operations and strategic cost management are crucial to our success. Our Biologics Market Access team is dedicated to demonstrating the tangible value we bring to our partnerships with PBMs and payers.

We approach drug costs from a holistic perspective, focusing not just on pricing but on the hidden costs of non-adherence and preventable side effects, which can result in expensive ER visits. Our personalized patient care management programs are tailored to individual risk assessments, providing the precise level of care needed to achieve optimal outcomes and reduce unnecessary costs.

Hidden costs driven by poor adherence and reduced productivity

$100 B

Dollars spent on medication related hospitalizations

33-66 %

Hospitalizations driven by poor adherence

$637 B

Estimated revenue losses to pharma

$16 K

Per patient losses due to reduced productivity
We know our approach works
Explore our case study detailing a successful partnership with a PBM, showcasing the remarkable achievements possible when we unite for the benefit of our patients.